Researchers from Fundacion Ciencia & Vida begin collaboration with Achilles Therapeutics for studies on kidney cancer


Researchers from Fundacion Ciencia & Vida, led by Dr. Alvaro Lladser and Vincenzo Borgna, begin collaboration with Achilles Therapeutics to advance their studies on human kidney cancer. The project is focused on analyzing cytotoxic T lymphocytes that infiltrate human kidney cancer tumors for their destruction and that, due to various factors, are unable to do so efficiently. Achilles Therapeutics, a UK-based biotech company developing precision cell therapies to treat multiple types of solid tumors, has provided funding to Fundacion Ciencia & Vida group of scientists. As a long-term goal, these studies seek to generate new therapies for kidney cancer patients who do not respond to currently available treatments.